New Novartis R&D centre in China
Fabrice Martin
Swiss pharmaceutical lab company Novartis announced its 8th R&D centre in Shanghaï, China.Mainly dedicated to research on infectious causes of prevalent cancers in China, this centre represents a USD 100 million investment. By establishing its new centre, which should employ more than 400 researchers by 2008, at the Zhangjiang Hi-Tech Park, near Shanghaï, Novartis bets on the development of this emerging life science cluster.
Operations are set to begin in May 2007.
More information about ABG?
Get ABG’s monthly newsletters including news, job offers, grants & fellowships and a selection of relevant events…
Discover our members
Ifremer 
Institut de Radioprotection et de Sureté Nucléaire - IRSN - Siège 
ONERA - The French Aerospace Lab 
MabDesign 
Laboratoire National de Métrologie et d'Essais - LNE 
Généthon 
PhDOOC 
ANRT 
Groupe AFNOR - Association française de normalisation 
CESI 
Institut Sup'biotech de Paris 
Aérocentre, Pôle d'excellence régional 
ADEME 
Tecknowmetrix 
Nokia Bell Labs France 
TotalEnergies - MabDesign
CASDEN 
SUEZ
